We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
-$7M
Cap. Flow
-$8.26M
Cap. Flow %
-8.11%
Top 10 Hldgs %
20.24%
Holding
121
New
2
Increased
37
Reduced
75
Closed
7

Top Buys

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$758K
2
PRCT icon
Procept Biorobotics
PRCT
+$353K
3
SOFI icon
SoFi Technologies
SOFI
+$242K
4
XYL icon
Xylem
XYL
+$169K
5
TXG icon
10x Genomics
TXG
+$139K

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$1.33M
2
SHOP icon
Shopify
SHOP
+$940K
3
UPST icon
Upstart Holdings
UPST
+$881K
4
SGFY
Signify Health, Inc.
SGFY
+$672K
5
ISRG icon
Intuitive Surgical
ISRG
+$666K

Sector Composition

Rank Sector Weight
1 Technology 48.69%
2 Healthcare 34.91%
3 Financials 8.37%
4 Industrials 6.21%
5 Consumer Discretionary 1.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
76
Bruker
BRKR
$9.2B
$613K 0.6%
11,547
-1,856
-14% -$111K
NRIX icon
77
Nurix Therapeutics
NRIX
$2.43B
$611K 0.6%
46,915
-2,302
-5% -$36.4K
TDY icon
78
Teledyne Technologies
TDY
$30.4B
$603K 0.59%
1,788
-103
-5% -$39.3K
VEEV icon
79
Veeva Systems
VEEV
$30.3B
$589K 0.58%
3,573
-194
-5% -$38.8K
TNDM icon
80
Tandem Diabetes Care
TNDM
$1.17B
$572K 0.56%
11,959
-2,299
-16% -$126K
MRNA icon
81
Moderna
MRNA
$21.5B
$563K 0.55%
4,759
-142
-3% -$21.5K
GPN icon
82
Global Payments
GPN
$22.1B
$561K 0.55%
5,193
-177
-3% -$21.8K
ITCI
83
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$561K 0.55%
12,063
-158
-1% -$8.25K
RNAM
84
DELISTED
Avidity Biosciences
RNAM
$556K 0.55%
34,019
-627
-2% -$12K
COIN icon
85
Coinbase
COIN
$41.7B
$517K 0.51%
8,018
-955
-11% -$66.7K
BCYC
86
Bicycle Therapeutics
BCYC
$270M
$502K 0.49%
21,594
-1,425
-6% -$33.9K
CPAY icon
87
Corpay
CPAY
$24.2B
$493K 0.48%
2,801
-96
-3% -$20.6K
GWRE icon
88
Guidewire Software
GWRE
$11.5B
$489K 0.48%
7,935
-677
-8% -$48.9K
ENV
89
DELISTED
ENVESTNET, INC.
ENV
$489K 0.48%
11,003
-732
-6% -$39.1K
FIS icon
90
Fidelity National Information Services
FIS
$21.5B
$483K 0.47%
6,394
-218
-3% -$20.3K
A icon
91
Agilent Technologies
A
$39.1B
$480K 0.47%
3,953
-1,042
-21% -$134K
MDGL icon
92
Madrigal Pharmaceuticals
MDGL
$12.6B
$471K 0.46%
7,249
-35
-0.5% -$2.43K
ARVN icon
93
Arvinas
ARVN
$518M
$463K 0.46%
10,414
+114
+1% +$5.54K
ISRG icon
94
Intuitive Surgical
ISRG
$121B
$459K 0.45%
2,451
-3,102
-56% -$666K
VRNS icon
95
Varonis Systems
VRNS
$5.25B
$455K 0.45%
17,168
-1,979
-10% -$56.5K
OM icon
96
Outset Medical
OM
$74.9M
$454K 0.45%
1,899
-282
-13% -$75.5K
TMO icon
97
Thermo Fisher Scientific
TMO
$211B
$447K 0.44%
881
-225
-20% -$126K
EW icon
98
Edwards Lifesciences
EW
$47.6B
$427K 0.42%
5,163
-854
-14% -$82.2K
FATE icon
99
Fate Therapeutics
FATE
$281M
$425K 0.42%
18,946
-528
-3% -$15.3K
PEGA icon
100
Pegasystems
PEGA
$4.41B
$423K 0.42%
26,302
+1,422
+6% +$28.9K
1 2 3
4
5

Similar funds

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
SC
Sonen Capital San Francisco, California $52.7M AUM 25.58% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
ACJ
Autonomy Capital (Jersey) St. Helier, Jersey $54.8M AUM 37.27% 1-Year Est. Return
UFG
United Fire Group Cedar Rapids, Iowa $55M AUM 6% 1-Year Est. Return
KC
Kellner Capital New York $55.5M AUM 88.05% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return

AtonRa Partners's Q3 2022 Portfolio in Review

As of Q3 2022, AtonRa Partners held 121 positions worth $102M, down 6.4% from $109M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

AtonRa Partners withdrew a net $8.26M in Q3 2022, closing 7 positions and reducing 75 holdings. Its most notable exit was Upstart Holdings, an estimated $881K position sold in full.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 48% a quarter earlier, followed by Healthcare and Financials.

Against the trend, AtonRa Partners opened a new position in R1 RCM Inc. Common Stock worth $616K.

  • AtonRa Partners's largest Q3 2022 buy was R1 RCM Inc. Common Stock: 33,252 shares worth $616K.
  • AtonRa Partners added most to Procept Biorobotics in Q3 2022, an estimated $353K increase.
  • AtonRa Partners's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $1.33M.
  • AtonRa Partners fully exited Upstart Holdings in Q3 2022, selling an estimated $881K.
  • AtonRa Partners's ten largest holdings make up 20% of its $102M portfolio in Q3 2022.
  • AtonRa Partners opened 2 new positions and closed 7 in Q3 2022.
  • AtonRa Partners's portfolio value fell 6.4% quarter-over-quarter to $102M.

Based on AtonRa Partners's 13F filing for Q3 2022, filed 14 Nov 2022.